Viewing nowS-one MP Tablet 40 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

MFDS item code 201402464 · Approved 2014.05.30 · Insurance code 671805720
Treatment and prevention of gastroesophageal reflux disease, gastric and duodenal ulcers and gastrointestinal symptoms, and Zollinger-Ellison syndrome
This medication is used for the treatment of gastroesophageal reflux disease, particularly for erosive reflux esophagitis and long-term maintenance therapy to prevent recurrence. It is also effective for the treatment and prevention of duodenal ulcers and peptic ulcers associated with Helicobacter pylori infection. It helps treat and prevent upper gastrointestinal symptoms and gastric ulcers associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs) and is used to treat Zollinger-Ellison syndrome. Finally, it is also applicable as a maintenance therapy following the prevention of rebleeding caused by gastric ulcers or duodenal ulcers. Overall, it is widely used for the treatment and prevention of gastrointestinal diseases.
This drug should be swallowed with a liquid such as water; do not chew or crush it. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Concomitant antibiotic therapy for eradication of Helicobacter pylori Administer this drug 20 mg concomitantly with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, and burning sensation) associated with use of nonsteroidal anti-inflammatory drugs (COX-2 nonselective or selective) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials extending beyond 4 weeks have not been conducted. 4) Patients requiring continuous use of nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. Thereafter, the dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into 2 doses. 6) Maintenance therapy following induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous administration Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous administration. 4. Renal impairment: No dose adjustment is necessary. Use caution because there is limited experience in patients with severe renal impairment. 5. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Do not exceed a dose of 20 mg of this drug in patients with severe hepatic impairment. 6. Elderly patients: No dose adjustment is necessary.
Adolescents aged 12 years and older - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Adolescents aged 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents aged 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Children under 12 years of age: There is no experience with administration of this drug to children under 12 years of age.
This medication should not be administered to certain patients. For example, patients with an allergy to this medication, any of its ingredients, or benzimidazole class drugs, or with a history of hypersensitivity should not take this medication. Furthermore, patients allergic to penicillin antibiotics or macrolide antibiotics used in the eradication treatment for Helicobacter pylori should also refrain from using this medication. Serious interactions may occur when this medication is taken with certain specific drugs; therefore, patients taking terfenadine, cisapride, pimodidine, or astemizole should not use this medication concurrently. Additionally, patients taking antiviral drugs such as atazanavir or nelfinavir should avoid this medication. The safety of this medication during breastfeeding has not been established, so nursing mothers should avoid its use. Patients with a history of myocardial infarction or currently experiencing myocardial infarction should also not be treated with this medication. Various adverse reactions may occur while taking this medication, with common symptoms including headache, abdominal pain, diarrhea, constipation, nausea, and vomiting. Rarely, serious side effects such as reduction in blood cell counts, hypersensitivity reactions, hypomagnesemia, mental confusion, skin rash, and abnormal liver function have been reported. Notably, if symptoms of muscle pain or weakness occur, there is a possibility of severe muscle damage called rhabdomyolysis, so immediate consultation with a doctor is necessary. This medication can increase bacterial proliferation in the stomach by suppressing gastric acid secretion, which may increase the risk of diarrhea caused by Clostridium difficile in hospitalized patients. Patients taking this medication for a long period (especially over one year) should have regular blood tests and magnesium level checks, and caution is required for those with osteoporosis as the risk of fractures may increase. During treatment with this medication, there are many interactions with other drugs, so especially when taken together with warfarin, digoxin, methotrexate, or clopidogrel, consultation with a physician or pharmacist and monitoring are necessary. The safety of this medication during pregnancy has not been fully established, so it should be used cautiously in pregnant women, and it is safe not to take it if breastfeeding. In cases of overdose, there is no specific antidote; symptomatic treatment based on symptoms may be necessary, and it should be kept out of the reach of children. Additionally, for quality maintenance, it is recommended to avoid transferring it to another container.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, eosinophilia, drug reactions with systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distention, allergic reaction, back pain, chest pain, retrosternal pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, lethargy, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid enlargement, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal dysmotility, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, vomiting, earache, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, nosebleeds, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, cramps, fibromyalgia syndrome, hernia, polymyalgia rheumatica, arthralgia, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonia, anxiety, sensory impairment, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disorders, tremors, dizziness, visual field loss, paresthesia, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, worsening asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, phantom smell, taste loss, taste disturbance, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, urination frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, stomach ulcer, gastritis, benign polyp, nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic gland polyp, hypocalcemia, hypokalemia, rhabdomyolysis, myalgia, asthenia
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a sealed container. The recommended storage temperature is between 1 degree and 30 degrees Celsius at room temperature. This helps maintain the medication's effectiveness for a long time.
Pink, round film-coated tablet
For domestic use: 28 tablets (14 tablets/PTP x 2) For export: 28 tablets (14 tablets/PTP x 2), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.